DK2679220T3 - Osmotisk pumpe-tablet med kontrolleret porøsitet og fremgangsmåde til fremstilling deraf - Google Patents

Osmotisk pumpe-tablet med kontrolleret porøsitet og fremgangsmåde til fremstilling deraf Download PDF

Info

Publication number
DK2679220T3
DK2679220T3 DK13162439T DK13162439T DK2679220T3 DK 2679220 T3 DK2679220 T3 DK 2679220T3 DK 13162439 T DK13162439 T DK 13162439T DK 13162439 T DK13162439 T DK 13162439T DK 2679220 T3 DK2679220 T3 DK 2679220T3
Authority
DK
Denmark
Prior art keywords
preparation
osmotic pump
controlled porosity
pump tablet
porosity osmotic
Prior art date
Application number
DK13162439T
Other languages
English (en)
Inventor
Jingang Wang
Haisong Jiang
Original Assignee
Cosci Med Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosci Med Tech Co Ltd filed Critical Cosci Med Tech Co Ltd
Application granted granted Critical
Publication of DK2679220T3 publication Critical patent/DK2679220T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK13162439T 2006-10-16 2007-10-16 Osmotisk pumpe-tablet med kontrolleret porøsitet og fremgangsmåde til fremstilling deraf DK2679220T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200610140521A CN100584319C (zh) 2006-10-16 2006-10-16 群孔释放渗透泵控释片及其制备方法
EP07816581.8A EP2085078B1 (en) 2006-10-16 2007-10-16 Controlled porosity osmotic pump tablet of high permeable drugs and the preparation method thereof

Publications (1)

Publication Number Publication Date
DK2679220T3 true DK2679220T3 (da) 2019-11-18

Family

ID=37816128

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07816581.8T DK2085078T3 (da) 2006-10-16 2007-10-16 Osmotisk pumpetablet af højpermeable lægemidler med kontrolleret porøsitet og fremgangsmåde til fremstilling deraf
DK13162439T DK2679220T3 (da) 2006-10-16 2007-10-16 Osmotisk pumpe-tablet med kontrolleret porøsitet og fremgangsmåde til fremstilling deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK07816581.8T DK2085078T3 (da) 2006-10-16 2007-10-16 Osmotisk pumpetablet af højpermeable lægemidler med kontrolleret porøsitet og fremgangsmåde til fremstilling deraf

Country Status (8)

Country Link
US (1) US8703193B2 (da)
EP (2) EP2085078B1 (da)
CN (1) CN100584319C (da)
DK (2) DK2085078T3 (da)
ES (2) ES2755716T3 (da)
HK (1) HK1136962A1 (da)
PL (2) PL2679220T3 (da)
WO (1) WO2008052417A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100584319C (zh) * 2006-10-16 2010-01-27 北京科信必成医药科技发展有限公司 群孔释放渗透泵控释片及其制备方法
CN101642443B (zh) * 2008-08-08 2011-09-21 鲁南制药集团股份有限公司 单硝酸异山梨酯渗透泵型控释制剂及其制备方法
CN101642444B (zh) * 2008-08-08 2011-09-21 鲁南制药集团股份有限公司 单硝酸异山梨酯双速渗透泵型控释制剂及其制备方法
CN101766581B (zh) * 2008-12-30 2012-08-15 北京科信必成医药科技发展有限公司 一种群孔释放的盐酸地尔硫卓择时控释片及其制备方法
EP2437733A4 (en) * 2009-06-02 2014-01-08 Dow Global Technologies Llc RETARD-PHARMACEUTICAL FORM
CN101953822B (zh) * 2010-07-30 2012-05-30 合肥立方制药股份有限公司 一种盐酸文拉法辛控释片及其制备方法
CN102670553A (zh) * 2011-03-14 2012-09-19 北京天衡药物研究院 盐酸文拉法辛渗透泵控释片
CN102349878B (zh) * 2011-10-14 2016-05-11 北京科信必成医药科技发展有限公司 一种微孔释放渗透泵控释片及其制备方法
CN102349879B (zh) * 2011-10-14 2016-07-13 北京科信必成医药科技发展有限公司 一种去甲文拉法辛控释片及其制备方法
WO2014181195A2 (en) 2013-03-14 2014-11-13 Redhill Biopharma Ltd. Antiemetic extended release solid dosage forms
CN104127401A (zh) * 2013-08-28 2014-11-05 山东绿叶制药有限公司 含有去甲基文拉法辛苯甲酸酯类化合物的渗透泵控释组合物
MX2016011734A (es) 2014-03-11 2017-02-13 Redhill Biopharma Ltd Formas de dosificacion sólida de liberación extendida de onndasetrón para trtar bien sea síntomas de náusea, vómito o diarrea.
WO2016132218A1 (en) 2015-02-20 2016-08-25 Osmotica Kereskedelmi Es Szolgaltato Kft Method of administering r-baclofen in an extended release dosage form
US10172800B2 (en) 2015-02-20 2019-01-08 Osmotica Kereskedelmi Es Szolgaltato Kft Controlled release dosage form with enhanced pharmacokinetics
US10300032B2 (en) 2015-02-20 2019-05-28 Osmotica Kereskedelmi Es Szolgaltato Kft Controlled release dosage form
US10987328B2 (en) 2015-02-20 2021-04-27 Osmotica Kereskedelmi Es Szolgaltato Kft Controlled release dosage form
EP3768378A4 (en) 2018-03-22 2021-11-17 InCarda Therapeutics, Inc. INNOVATIVE METHOD OF SLOWING THE VENTRICULAR RATE
CN112999179B (zh) * 2019-12-20 2024-02-23 成都康弘药业集团股份有限公司 一种含盐酸文拉法辛的药物组合物
CN117338741B (zh) * 2023-09-20 2024-05-24 江苏神华药业有限公司 一种治疗心律失常的单室渗透泵片及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US6046177A (en) 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
JP3950175B2 (ja) * 1997-05-30 2007-07-25 オスモティカ・コーポレイション 多層浸透デバイス
US8293799B2 (en) * 2003-12-29 2012-10-23 Osmotica Keresleedelmo és Szolgáltató KFT Osmotic device containing a venlafaxine salt and a salt having an ion in common
US8029822B2 (en) * 2003-05-22 2011-10-04 Osmotica Kereskedelmi és Seolgáltató KFT Rupturing controlled release device having a preformed passageway
CN100463676C (zh) * 2004-11-11 2009-02-25 成都康弘药业集团股份有限公司 一种盐酸文拉法辛控释片制剂及其制备方法
CN100584319C (zh) * 2006-10-16 2010-01-27 北京科信必成医药科技发展有限公司 群孔释放渗透泵控释片及其制备方法

Also Published As

Publication number Publication date
EP2679220B1 (en) 2019-08-21
EP2085078A4 (en) 2011-10-05
CN100584319C (zh) 2010-01-27
DK2085078T3 (da) 2014-02-17
PL2085078T3 (pl) 2014-05-30
WO2008052417A1 (fr) 2008-05-08
ES2446267T3 (es) 2014-03-06
US8703193B2 (en) 2014-04-22
HK1136962A1 (en) 2010-07-16
EP2085078B1 (en) 2013-11-20
US20100291208A1 (en) 2010-11-18
CN1923184A (zh) 2007-03-07
EP2679220A1 (en) 2014-01-01
PL2679220T3 (pl) 2020-04-30
ES2755716T3 (es) 2020-04-23
EP2085078A1 (en) 2009-08-05

Similar Documents

Publication Publication Date Title
DK2679220T3 (da) Osmotisk pumpe-tablet med kontrolleret porøsitet og fremgangsmåde til fremstilling deraf
DK2091510T3 (da) Fortykkede tensidsystemer, der omfatter mikrofibrøs cellulose, og fremgangsmåder til fremstilling heraf
DK1973429T3 (da) Proteinhydrolysater og fremgangsmåde til fremstilling
DK2044076T3 (da) Fremgangsmåde til fremstilling af asenapin og intermediatprodukter, som anvendes i fremgangsmåden
DK2022879T3 (da) Nonwoven-stoflaminat og fremgangsmåde til fremstilling deraf
DK2079355T3 (da) Fremgangsmåde og system til brilleordination
NO20073245L (no) Fremgangsmate og system til dannelse av flytende LNG
DK2063980T3 (da) Isoporøs membran og fremgangsmåde til fremstilling deraf
DK1773708T3 (da) Apparat til farmaceutisk produktion
DK2358669T3 (da) Alpha-keto-persyrer og fremgangsmåder til fremstilling og anvendelse heraf
DK2029799T3 (da) Termostabile proteiner og fremgangsmåder til fremstilling og anvendelse heraf
DK3428148T3 (da) Aryloazol-2-yl-cyanoethylaminoforbindelser, fremgangsmåde til fremstilling og fremgangsmåde til anvendelse deraf
NO20091424L (no) Substituerte amider, fremgangsmåte for fremstilling derav og anvendelse derav
NO20091426L (no) Substituerte amider, fremgangsmåte for fremstilling derav og anvendelse derav
DK1943016T3 (da) Kompositnanopartikler, nanopartikler og fremgangsmåder til fremstilling heraf
DK2471807T3 (da) Langtids-virkende polypeptider og fremgangsmåder til produktion og administration af samme
DK2427166T3 (da) Tabletfremstillingsmodul og fremgangsmåde til kontinuerlig fremstilling af tabletter
DK2346552T4 (da) Lægemiddelafgivelsesanordning og fremgangsmåde til fremstilling af en lægemiddelafgivelsesanordning
DK2209375T3 (da) Parp-inhibitorforbindelser, præparater og fremgangsmåder til anvendelse deraf
DK2147315T3 (da) Diabetesrelaterede biomarkører og fremgangsmåder til anvendelse deraf
DK1979061T3 (da) Forbindelsesorgan til konstruktionselementer og byggebloksæt med dette
DK2134663T3 (da) Beskyttelseslag på højtemperaturudholdende chromoxiddannende substrater, og fremgangsmåde til fremstilling deraf
DK1988090T3 (da) Imidazol-5-carboxylsyrederivater, fremgangsmåder til fremstilling af disse og anvendelse deraf
DK2309938T3 (da) Kryokirurgiske systemer og fremgangsmåder til anvendelse heraf
DK2107055T3 (da) Dosmetinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse